Erika N Hanson (Erika Amini)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Advanced Non Small Cell Lung Cancer

Top Venues

Journal of genetic counseling

JCO oncology practice

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Austin, Erika N Hanson, Emerson L Delacroix, Elizabeth Bacon, John Rice, Lynette Hammond Gerido, Elizabeth Rizzo, Versha A Pleasant, Elena M Stoffel, Jennifer J Griggs, Kenneth Resnicow
Impact of barriers and motivators on intention and confidence to undergo hereditary cancer genetic testing. Journal of genetic counseling (2024)
Erika N Hanson, Emerson L Delacroix, Sarah Austin, Grant Carr, Kelley M Kidwell, Elizabeth Bacon, Lynette Hammond Gerido, Jennifer J Griggs, Elena M Stoffel, Kenneth Resnicow
Psychosocial factors impacting barriers and motivators to cancer genetic testing. Cancer medicine (2023)
Anthony J Scott, Arathi Mohan, Sarah Austin, Erika N Hanson, Shelby M Raupp, Brittany Pannecouk, Michael J Kelley, Goutham Narla, Nithya Ramnath
Integrating Medical Genetics Into Precision Oncology Practice in the Veterans Health Administration: The Time Is Now. JCO oncology practice 18 (6) (2022)
Kenneth Resnicow, Emerson L Delacroix, Gabriela Chen, Sarah Austin, Elena Stoffel, Erika N Hanson, Lynette Hammond Gerido, Kimberly A Kaphingst, Beverly M Yashar, Monica Marvin, Jennifer J Griggs, Deborah L Cragun
Motivational interviewing for genetic counseling: A unified framework for persuasive and equipoise conversations. Journal of genetic counseling 31 (5) (2022)
Fallon K Noto, Jaya Sangodkar, Bisoye Towobola Adedeji, Sam Moody, Christopher B McClain, Ming Tong, Eric Ostertag, Jack Crawford, Xiaohua Gao, Lauren Hurst, Caitlin M O'Connor, Erika N Hanson, Sudeh Izadmehr, Rita Tohmé, Jyothsna Narla, Kristin LeSueur, Kajari Bhattacharya, Amit Rupani, Marwan K Tayeh, Jeffrey W Innis, Matthew D Galsky, B Mark Evers, Analisa DiFeo, Goutham Narla, Tseten Y Jamling
The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies. PloS one 15 (10) (2020)